Cardiothoracic anesthesiology

Revelation Biosciences Inc. Appoints Dr. Julia Bohannon and Dr. Antonio Hernandez to Scientific Advisory Board

Retrieved on: 
Monday, March 13, 2023

Dr. Hernandez and Dr. Bohannon are inventors of the phosphorylated hexaacyl disaccharide (PHAD) based technology licensed from Vanderbilt University, previously announced on October 6, 2022 .

Key Points: 
  • Dr. Hernandez and Dr. Bohannon are inventors of the phosphorylated hexaacyl disaccharide (PHAD) based technology licensed from Vanderbilt University, previously announced on October 6, 2022 .
  • Julia Bohannon, Ph.D. is an Associate Professor in the Department of Anesthesiology and the Department of Pathology, Microbiology and Immunology at Vanderbilt University Medical Center.
  • Dr. Antonio Hernandez is a Professor of Anesthesiology Critical Care Medicine, Cardiothoracic Anesthesiology, Research at Vanderbilt University Medical Center, Co-Medical Director, CV-ICU.
  • Hernandez and Dr. Bohannon bring a wealth of knowledge and experience in treatment of infection by augmenting the innate immune response, a form of trained immunity.

New Study Demonstrates Retia Medical's Multi-Beat Analysis (MBA™) Algorithm is More Accurate Than a Competing Cardiac Output Monitoring Technology in Cardiac Surgery

Retrieved on: 
Friday, July 16, 2021

The measurements from each monitor were compared to the reference, thermodilution measurements from an invasive, pulmonary artery catheter (PAC).

Key Points: 
  • The measurements from each monitor were compared to the reference, thermodilution measurements from an invasive, pulmonary artery catheter (PAC).
  • "The Argos device is superior to other non-invasive cardiac output monitors on the market and remains precise across a myriad of conditions.
  • Off-pump coronary artery bypass graft surgery is a challenging cardiac surgery where patients experience significant hemodynamic variations.
  • Retia Medical's Argos Monitor, with its Multi-Beat Analysis (MBATM) algorithm, eliminates a critical problem with older cardiac output technologies.

Howard Shackelford, MD, FACS, FACC, is being recognized by Continental Who's Who

Retrieved on: 
Monday, June 21, 2021

Having garnered 45 years of professional excellence in his field, Dr. Howard Shackelford is a board-certified and respected Cardiothoracic Surgeon.

Key Points: 
  • Having garnered 45 years of professional excellence in his field, Dr. Howard Shackelford is a board-certified and respected Cardiothoracic Surgeon.
  • Dr. Shackelford is chairman of the Wheeling Hospital's Cardiac, Thoracic, and Vascular Services in his current capacity.
  • As a surgeon, he devotes his work to providing the highest standard of general, vascular, and trauma surgeries for his patients.
  • With a commitment to excellence, Dr. Shackelford is board-certified by the American Board of Surgery and the American Board of Thoracic Surgery.

Heart & Vascular Center at Valley View Offers Open Heart Surgery and New Cardiothoracic Procedures, Under the Leadership of Cardiothoracic Surgeon Stephen Jones, MD

Retrieved on: 
Wednesday, June 9, 2021

Stephen Jones, MDhas begun an open heart surgical program at Valley View with 10 open heart procedures performed to date.

Key Points: 
  • Stephen Jones, MDhas begun an open heart surgical program at Valley View with 10 open heart procedures performed to date.
  • Valley View now offers a wide range of treatments and the most experienced cardiothoracic surgeon on Colorado's Western Slope.
  • Dr. Jones joins the Heart & Vascular Center from St. Alphonsus Regional Medical Center in Boise, Idaho, where he was the chief of Cardiothoracic Surgery for 10 years.
  • "We are very pleased to welcome Dr. Jones to Valley View," said Brian Murphy, MD, CEO of Valley View.

Abdulla A. Attum, MD, FACS is recognized by Continental Who's Who

Retrieved on: 
Friday, May 7, 2021

As a board-certified cardiothoracic surgeon, Dr. Attum has led an impressive career, having accrued many years of professional experience in his field.

Key Points: 
  • As a board-certified cardiothoracic surgeon, Dr. Attum has led an impressive career, having accrued many years of professional experience in his field.
  • He specializes in open-heart procedures, off-pump bypass, valve surgery, lung and chest wall resections, and complex cardiac procedures.
  • He takes pride in maintaining the lowest complication rates nationally, and treats all patients as if they were his family.
  • Attum decided to become a cardiothoracic surgeon in 1967, when he heard about the first-ever human heart transplant operation.

First Study of Thoraguard Digital Drainage System Completed at Stanford University Medical Center

Retrieved on: 
Tuesday, January 21, 2020

Centese, Inc. today announced completion of the first clinical study of its Thoraguard digital drainage system used in cardiac surgery at Stanford University Medical Center.

Key Points: 
  • Centese, Inc. today announced completion of the first clinical study of its Thoraguard digital drainage system used in cardiac surgery at Stanford University Medical Center.
  • We are enthusiastic about studying this new digital drainage system designed to clear chest tubes automatically.
  • The Stanford study encompassed 25 patients undergoing non-emergent cardiac surgery, such as coronary artery bypass surgery or heart valve replacement, with whom Thoraguard was used as the exclusive post-operative drainage system.
  • Thoraguard is a next-generation digital drainage system designed to protect patients and improve the accuracy of post-operative clinical decision-making.

New Published Clinical Trial Results Confirm that PleuraFlow Enables Improved Quality and Cost of Care for Cardiac Surgery Patients

Retrieved on: 
Wednesday, November 20, 2019

ClearFlow, Inc., a medical device company based in Irvine, California, has announced positive clinical trial results published in the peer-reviewed Journal of Cardiothoracic Surgery.

Key Points: 
  • ClearFlow, Inc., a medical device company based in Irvine, California, has announced positive clinical trial results published in the peer-reviewed Journal of Cardiothoracic Surgery.
  • The trial evaluated the use of the PleuraFlow Active Clearance Technology (ACT) System in prevention of retained blood complications in heart surgery patients.
  • PleuraFlow is a medical device used at the bedside in the ICU that enables clinicians to proactively maintain chest tube patency following cardiac surgery without breaking the sterile field.
  • We appreciate the opportunity to partner globally with clinical teams in enabling enhanced recovery for cardiac surgery patients.

$27.23 B Worth Cardiovascular Surgery Devices Market - TBRC Report Says North America To Remain Largest for Next 5yrs

Retrieved on: 
Wednesday, September 18, 2019

Due to these factors, higher number of surgeries are being performed, thereby driving the cardiovascular surgery devices and equipment market.

Key Points: 
  • Due to these factors, higher number of surgeries are being performed, thereby driving the cardiovascular surgery devices and equipment market.
  • The cardiovascular surgery devices and equipment market consists of sales of cardiovascular surgery devices and related services.
  • Cardiovascular surgery devices are segmented into perfusion disposables, beating heart surgery systems, cardiopulmonary bypass equipment, and cardiac ablation devices.
  • North America was the largest region in the cardiovascular surgery devices and equipment market in 2018.

Enhanced Recovery After Surgery (ERAS) Sessions to be Held at the AATS 99th Annual Meeting

Retrieved on: 
Tuesday, March 19, 2019

For the second year in a row, dedicated ERAS Cardiac and Thoracic Surgery sessions will be held at the American Association for Thoracic Surgery 99th Annual meeting on May 4-7 in Toronto, Canada.

Key Points: 
  • For the second year in a row, dedicated ERAS Cardiac and Thoracic Surgery sessions will be held at the American Association for Thoracic Surgery 99th Annual meeting on May 4-7 in Toronto, Canada.
  • The sessions will include 17 selected high-quality peer-reviewed abstracts and separate sessions dedicated to preoperative, intraoperative, and postoperative interventions to optimize the care of both cardiac and thoracic surgical patients.
  • ERAS Cardiac is a non-profit organization with the mission to develop evidence-based expert consensus statements promoting best practice recovery practices.
  • Focusing on cardiac surgery, our organization is collaborating with ERAS ( www.erassociety.org ), an organization that promotes enhanced recovery in many other surgical specialties worldwide.

For the Fifth Time Phoenix Children's Earns Top Rating From The Society of Thoracic Surgeons' Congenital Heart Surgery Database

Retrieved on: 
Tuesday, September 18, 2018

The newest rating is based on congenital cardiothoracic surgery outcomes data for the period from January 2014 through December 2017.

Key Points: 
  • The newest rating is based on congenital cardiothoracic surgery outcomes data for the period from January 2014 through December 2017.
  • The Cardiothoracic Surgery team at Phoenix Children's is one of just 12 programs in North America to earn this rating out of 119 participating programs.
  • "We want to be known as the safest surgical option for children who suffer from heart defects," said Daniel Velez, MD, Division Chief of Cardiothoracic Surgery at Phoenix Children's.
  • Star designations are measured on the overall risk-adjusted observed-to-expected operative morality ratio for all patients undergoing pediatric and/or congenital cardiac surgery, using the Congenital Heart Surgery Database (CHSD) mortality risk model.